Cadila Healthcare renamed as Zydus Lifesciences
Zydus unveils its ‘innovation and care’-centric corporate brand identity
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cadila Healthcare
DCGI gives nod to Cadila Healthcare to conduct phase-III trials for two-dose COVID vaccine
The company has already received the Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for…
India’s COVID vaccine supply increases, raising export hopes
After donating or selling 66 million doses to nearly 100 countries, India barred exports in the middle of April to focus on…
Dr Reddy’s and Zydus Pharma recall products in US market
As per the US FDA report, Zydus Pharmaceuticals (USA) is recalling 2,880 bottles of Carvedilol tablets, USP 25 mg in the US due to…
Zydus partners with CHEMI to launch enoxaparin sodium injection
Under the agreement, CHEMI will manufacture and supply the enoxaparin sodium injection, which Zydus will commercialise in the US
Cadila Healthcare’s net profit rises 29 per cent in Q1
Consolidated total revenue from operations stood at Rs 4,025.4 crores for the quarter under consideration against Rs 3,514.6…
Zydus applies to DCGI for EUA to launch ZyCoV-D
The COVID-19 vaccine has been tested in adolescent population in the 12-18 years age group in India as well
Bayer and Zydus extend their JV for three years
The joint venture will continue to operate in therapies including cardiology, diabetes, women’s health, ophthalmology and…
Cadila Healthcare to make around 30 million doses of COVID-19 vaccine a month: Managing Director
The company will use both in-house capacity as well as third-party manufacturers to boost production
Zydus launches Ujvira (trastuzumab emtansine) for breast cancer treatment
The drug is being offered at Rs 32495 for a 100 mg vial